Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2023 – Feb 2024Where it's discussed
-
X / Twitter27 posts
-
News27 articles
-
Blogs4 articles
-
YouTube3 videos
AI synopsis
What people are saying
The collective discussions reflect strong interest and engagement through mentions of specific mechanisms like CDK4/6 activity restoring cell proliferation and the potential for combination therapies, using language such as 'promising' and 'resistance,' which underscores the significance of the research. The tone ranges from informative to hopeful, indicating that the publication is considered impactful for advancing cancer treatment strategies.
Most discussions acknowledge the significance of the findings, especially highlighting the challenge of cancer cell adaptation and the potential for combination therapies.
Posts show high interest, with many emphasizing the promising implications for resistant cancers and the detailed mechanisms involved.
There is deep engagement, as evidenced by references to molecular details like CDK4/6 activity, Rb1 phosphorylation, and the implications for treatment strategies.
The discussions suggest that these findings could influence future research and treatment approaches, but the overall impact remains optimistic rather than transformative.
Abstract in brief
- CDK2 is a key enzyme in the cell cycle that, when hyperactivated in cancers, presents a potential target for new treatments.
- Research shows that inhibiting CDK2 causes a quick drop in its activity, but cancer cells can adapt and restore its activity within hours, partly due to the compensatory effects of CDK4/6.
- Findings suggest that using inhibitors for both CDK2 and CDK4/6 together may be necessary to effectively prevent cancer cells from adapting and resisting treatment.
Top posts
Most liked on X and BlueskyRapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/uoq9INpxja
Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/TNacC14FRc
Study highlights promising drug combination for treating resistant breast cancer https://t.co/0dwf7rzPqY https://t.co/feTHInTFMl
Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/f3I6Xmn1j0 https://t.co/MAGT7NoPut
All mentions
CDK2 Inhibition and Cell Cycle Plasticity in Cancer Cells
This video demonstrates the rapid response of CDK2 activity in MCF10A cells treated with various inhibitors, highlighting the ability of cancer cells to adapt and restore cell cycle progression despite targeted…
Understanding Cell Cycle Plasticity and CDK2 Inhibition in Cancer Cells
This video examines how cancer cells rapidly adapt to CDK2 inhibition, highlighting the importance of combined CDK2 and CDK4/6 targeting to prevent resistance and improve treatment efficacy.
Analyzing CDK2 Inhibition and Cell Cycle Adaptability in Cancer Cells
Video shows rapid changes in CDK2 activity in treated cells, revealing cell cycle plasticity. Inhibition causes a quick drop, but cells may adapt within hours, highlighting the potential need for combined CDK2 and…
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
#Cell: #CDK4/6 activity backstops inhibition of #CDK2 and sustains the proliferative program by maintaining Rb1 hyperphosphorylation, active #E2F transcription, and cyclin A2 expression, enabling re-activation of CDK2 in the presence of drug. https://t.co/nX2dEKlnTY #cancer https://t.co/D1OuCY8VBw
Study highlights promising drug combination for treating resistant breast cancer https://t.co/0dwf7rzPqY https://t.co/feTHInTFMl
Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/uoq9INpxja
#Cell: CDK2 is a core cell-cycle kinase that #phosphorylates many substrates to drive progression through the cell cycle. Upon #CDK2 inhibition, cells exhibit a rapid loss of substrate phosphorylation that rebounds within several hours. #Cancer https://t.co/nX2dEKlnTY https://t.co/etDPNQwtos
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/f3I6Xmn1j0 https://t.co/MAGT7NoPut
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/psXysQI9Ql
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
RT @CellCellPress: Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
Now online! Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/jyJRfJ9sJZ
Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity https://t.co/TNacC14FRc